contrafect 7M grant
ContraFect has received a $7.2 Million grant from the US Army Medical Research and Development Command to advance their engineered phage lysin candidate CF-296 for Staphylococcus aureus infections.
Topics
ContraFect has received a $7.2 Million grant from the US Army Medical Research and Development Command to advance their engineered phage lysin candidate CF-296 for Staphylococcus aureus infections.